ArticleThoracic cancer2023

Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from Taiwan.

John Wen-Cheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.